These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26895379)

  • 61. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.
    Gostner JM; Becker K; Überall F; Fuchs D
    Expert Opin Ther Targets; 2015 May; 19(5):605-15. PubMed ID: 25684107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance.
    Hennequart M; Pilotte L; Cane S; Hoffmann D; Stroobant V; Plaen E; Van den Eynde BJ
    Cancer Immunol Res; 2017 Aug; 5(8):695-709. PubMed ID: 28765120
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
    Opitz CA; Litzenburger UM; Opitz U; Sahm F; Ochs K; Lutz C; Wick W; Platten M
    PLoS One; 2011; 6(5):e19823. PubMed ID: 21625531
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration.
    Yu K; Li D; Xu F; Guo H; Feng F; Ding Y; Wan X; Sun N; Zhang Y; Fan J; Liu L; Yang H; Yang X
    Int Immunopharmacol; 2021 May; 94():107446. PubMed ID: 33581581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IDO1 depletion induces an anti-inflammatory response in macrophages in mice with chronic viral myocarditis.
    Guo G; Sun L; Yang L; Xu H
    Cell Cycle; 2019 Oct; 18(20):2598-2613. PubMed ID: 31416389
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An overview on the methods of determining the activity of Indoleamine 2, 3-Dioxygenase 1.
    Zhao Y; Wang B; Liu J; Sun P; Liu H
    J Drug Target; 2019 Aug; 27(7):724-731. PubMed ID: 30215536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MiR-218 produces anti-tumor effects on cervical cancer cells in vitro.
    Zhu L; Tu H; Liang Y; Tang D
    World J Surg Oncol; 2018 Oct; 16(1):204. PubMed ID: 30314496
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Investigation of indoleamine 2,3-dioxygenase 1 expression in uveal melanoma.
    Liang C; Peng L; Zeng S; Zhao Q; Tang L; Jiang X; Zhang J; Yan N; Chen Y
    Exp Eye Res; 2019 Apr; 181():112-119. PubMed ID: 30639792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
    Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
    Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents.
    Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.
    Merlo LMF; DuHadaway JB; Montgomery JD; Peng WD; Murray PJ; Prendergast GC; Caton AJ; Muller AJ; Mandik-Nayak L
    Front Immunol; 2020; 11():1861. PubMed ID: 32973768
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition.
    Pan J; Yuan K; Peng S; Huang Y; Zhang Y; Hu Y; Feng Y; Shi Y; Liu Y; Wang H; Zhou N; Min W
    Int J Oncol; 2017 Jun; 50(6):2136-2144. PubMed ID: 28498425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors.
    Song X; Sun P; Wang J; Guo W; Wang Y; Meng LH; Liu H
    Eur J Med Chem; 2020 Mar; 189():112059. PubMed ID: 31981851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
    Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.
    Sun J; Yu J; Li H; Yang L; Wei F; Yu W; Liu J; Ren X
    J Exp Clin Cancer Res; 2011 Sep; 30(1):82. PubMed ID: 21917155
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis.
    Wei C; Mei J; Tang L; Liu Y; Li D; Li M; Zhu X
    Cell Death Dis; 2016 Dec; 7(12):e2489. PubMed ID: 27906184
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.
    Giannoni P; Pietra G; Travaini G; Quarto R; Shyti G; Benelli R; Ottaggio L; Mingari MC; Zupo S; Cutrona G; Pierri I; Balleari E; Pattarozzi A; Calvaruso M; Tripodo C; Ferrarini M; de Totero D
    Haematologica; 2014 Jun; 99(6):1078-87. PubMed ID: 24561793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.